News - Appointments

Iain McGill becomes CEO of Quell Therapeutics

Read more

Sylvie Ryckebusch joins board of Domain Therapeutics

Read more

ReViral names Alex Sapir as chief executive

Read more

Ulrich Platte becomes CFO at eTheRNA Immunotherapies

Read more

Valo Therapeutics appoints Michael Stein as CEO

Read more

Jan Ohrstrom becomes chief executive of Biom’up

Read more

Rosamond Deegan becomes CEO at OMass Therapeutics

Read more

Novigenix appoints Jan Groen as chief executive

Read more

Harald Hampel joins Eisai as head of global medical affairs

Read more

Mohammed Dar is CMO at Immunocore

Read more